Academia
In the world of cancer biology, not all biomarkers are created equal. These molecules that alert doctors that an abnormal process may be underway can appear as an array of aberrant proteins, such as hormones, enzymes or signaling molecules, and vary from patient to patient.
Researchers have narrowed down the malaria proteins and disease-fighting antibodies that could be used to develop a vaccine against the most severe forms of malaria.
A research team may have discovered a means to prevent breast cancer from spreading to other parts of the body through the blocking of a single enzyme.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Researchers from Karl Landsteiner University of Health Sciences have uncovered a new form of a virus that infects bacteria
The Weill Family Foundation, University of California, Berkeley, University of California, San Francisco and the University of Washington launched the Weill Neurohub with a $106 million gift.
Biomedical engineers at the University of Southern California developed a method using ultrasound to control and track drug release.
Researchers found neurons may shut down without dying and these “undead neurons” release molecules that shut down neighboring brain cells, which leads to the common Parkinson’s symptoms.
Maryland, MD: Syngene, a world-leading manufacturer of image analysis solutions, is pleased to announce it has entered a sponsorship agreement with Tufts Launchpad | BioLabs developed by Tufts University to be Boston’s premier fully equipped, co-working and shared lab space for biotech start-ups.
Could an immunosuppressant boost cognition in senior citizens? A recent animal study from the University of Texas Health Science Center at San Antonio suggests the possibility.
PRESS RELEASES